Asia
Daiichi Sankyo announced the decision in its third quarter financial report this morning, where it said that the Phase I data yielded no clear responses in GIST patients.
Yet another busy week for clinical trial news. Here’s a look.
The deal was struck one month after GammaDelta dosed its first patient in a Phase I acute myeloid leukemia (AML) trial.
Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.
While the volatility of the market has some shying away from going public, private investment dollars are still rolling in each week. Check out our top picks.
10X Genomics is continuing to increase its presence outside of the United States, this time with its first manufacturing facility outside of the country.
Scientists are scrambling to find the cause for the sudden spike in human cases of avian influenza A (H5N6) in China to 21 this year, from only five in 2020.
C2i Genomics plans to make sophisticated AI-informed cancer diagnostics and tumor monitoring available throughout the world, regardless of where patients or clinical trials are located.
It was yet another busy week for clinical trial news. Here’s a look.
Earlier this month, Catalent announced plans to add 500–600 jobs in Bloomington, Ind., one of its Moderna and Johnson & Johnson COVID-19 vaccine manufacturing sites.
PRESS RELEASES